Derma Pen v. 4EverYoung Limited

999 F.3d 1240
CourtCourt of Appeals for the Tenth Circuit
DecidedJune 8, 2021
Docket19-4114
StatusPublished
Cited by12 cases

This text of 999 F.3d 1240 (Derma Pen v. 4EverYoung Limited) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Derma Pen v. 4EverYoung Limited, 999 F.3d 1240 (10th Cir. 2021).

Opinion

FILED United States Court of Appeals Tenth Circuit PUBLISH June 8, 2021 UNITED STATES COURT OF APPEALS Christopher M. Wolpert FOR THE TENTH CIRCUIT Clerk of Court _________________________________

DERMA PEN, LLC,

Plaintiff - Appellant,

v. No. 19-4114

4EVERYOUNG LIMITED; BIOSOFT (AUST) PTY LTD, d/b/a DermapenWorld; EQUIPMED INTERNATIONAL PTY LTD, d/b/a DermapenWorld; STENE MARSHALL, d/b/a DermapenWorld,

Defendants.

------------------------------

DERMA PEN IP HOLDINGS, LLC,

Movant - Appellant,

JOEL MARSHALL; SASHA MARSHALL; DP DERM, LLC,

Movants - Appellees. _________________________________

Appeal from the United States District Court for the District of Utah (D.C. No. 2:13-CV-00729-DN-EJF) _________________________________

Dick J. Baldwin (Michael D. Zimmerman, Troy L. Booher, Taylor P. Webb with him on the briefs), Zimmerman Booher, Salt Lake City, Utah, and Kevin A. Turney, Salt Lake City, Utah, on the brief for Appellants. S. Ian Hiatt (Jefferson W. Gross with him on the brief), Gross & Rooney, Salt Lake City, Utah, for Appellees. _________________________________

Before HARTZ, Circuit Judge, LUCERO, Senior Circuit Judge, and EID, Circuit Judge. _________________________________

LUCERO, Senior Circuit Judge. _________________________________

After years of trademark litigation, Plaintiff-Appellant Derma Pen, LLC

(“Derma Pen”) was granted a permanent injunction against Stene Marshall and three

related corporations that he had formed. Shortly thereafter, Derma Pen moved for a

contempt order against Stene Marshall, alleging that he had violated the injunction.

Derma Pen also sought a contempt order against Stene Marshall’s brother and sister-

in-law, Joel and Sasha Marshall, and DP Derm, LLC, a corporation Joel and Sasha

own (collectively, the “Related Parties”). Movant-Appellant Derma Pen IP Holdings

LLC (“DPIPH”), Derma Pen’s successor in interest, joined Derma Pen’s motion

shortly before the contempt hearing. In its motion, Derma Pen asserted that the

Related Parties had acted in concert with Stene Marshall to violate the injunction.

The Related Parties prevailed in the contempt proceeding and subsequently moved

for attorney’s fees under the Lanham Act, 15 U.S.C. § 1117(a), which allows a

district court to award fees to a prevailing party in an “exceptional case” arising

under the Act. The court granted the motion for fees, and Derma Pen and DPIPH

appeal from that award.1

1 Appellants’ opening brief also asserts that the district court’s contempt determination was in error, but they correctly concede in their reply brief that we lack 2 In its award of attorney’s fees to the Related Parties, the trial court relied upon

a statutory provision in the Patent Act as interpreted by the Supreme Court in Octane

Fitness, LLC v. ICON Health & Fitness, Inc., 572 U.S. 545 (2014). We are called

upon to decide whether the term “exceptional case” in the Patent Act differs in

meaning from the same term used in the Lanham Act to a degree that requires

reversal. We conclude that the exceptional case standard in the Lanham Act parallels

the standard in the Patent Act and affirm.

I

In 2013, Derma Pen sued Stene Marshall and three corporations that he had

formed, alleging infringement of the “DERMAPEN” trademark (the “Mark”). On

May 8, 2017, as part of the judgment in this action, Derma Pen was granted a

permanent injunction prohibiting the defendants and “their officers, agents, servants,

employees, attorneys, licensees, and anyone in active concert or participation with,

aiding, assisting, or enabling Defendants” from using the Mark.

Several months later, on November 3, 2017, Derma Pen filed an ex parte

motion for an Order to Show Cause (OSC) for contempt, asserting that Stene

Marshall was violating the injunction. Derma Pen also alleged that Stene was acting

in concert with the Related Parties to violate the injunction and included them as

parties in the OSC.

appellate jurisdiction to decide that issue because they did not timely appeal the order. See Scrivner v. Sonat Exploration Co., 242 F.3d 1288, 1290 n.1 (10th Cir. 2001). 3 On June 8, 2018, the district court ordered Stene Marshall and the Related

Parties to appear before it regarding the alleged violations of the injunction. A

hearing was held on July 6, 2018, and the parties were ordered to stipulate to a

scheduling order for limited discovery. The scheduling order required Derma Pen to

identify the provisions of the injunction the Related Parties violated and to provide

contact information of those with discoverable information to support its allegations.

Derma Pen routinely failed to meet its discovery obligations, causing the Related

Parties to file six discovery motions over a four-month period and leading to

sanctions on Derma Pen.

Complicating the analysis, Derma Pen no longer had the rights to the Mark at

the time of the contempt proceeding. DPIPH was formed in 2015, acquired the rights

to the Mark shortly thereafter, and was subsequently joined to the underlying

litigation. Although DPIPH remained a party to the litigation, it did not seek to join

Derma Pen’s motion for an OSC until December 7, 2018—roughly ten days prior to

the scheduled evidentiary hearing and after a court order directing it to state on the

record whether it was seeking to enforce the injunction against the Related Parties.

DPIPH’s motion to join the contempt proceeding was subsequently granted.

After holding an evidentiary hearing in December 2018, the district court

issued a decision on February 14, 2019, holding Stene Marshall in contempt of the

injunction but concluding the Related Parties had not acted in concert with Stene

Marshall and had not violated the injunction. The Related Parties subsequently

moved for attorney’s fees incurred in the contempt proceeding under the Lanham

4 Act, which allows a prevailing party to recover fees in an “exceptional case.” 15

U.S.C. § 1117(a). Applying the definition of “exceptional case” set forth in Octane

Fitness, LLC v. ICON Health & Fitness, Inc., 572 U.S. 545 (2014), the district court

granted the motion and awarded the Related Parties $190,328 in fees.

The district court concluded that this case was exceptional based on the totality

of five factors: (1) Appellants “produced no evidence of damages” (emphasis in

original), (2) “the evidence showed Derma Pen had no right to enforce the

injunction,” (3) “the evidence showed that [the] trademark was abandoned,”

(4) “monetary sanctions were imposed on” Appellants for repeated failures to comply

with discovery orders, and (5) Appellants were “entitled to no relief against the

[Related Parties].”

An appeal is brought by Derma Pen and DPIPH.

II

We review orders granting or denying attorney’s fees under the Lanham Act

for abuse of discretion. King v. PA Consulting Grp., Inc., 485 F.3d 577, 592 (10th

Cir. 2007). However, we “review the underlying legal principles de novo.” Id. “A

district court abuses its discretion when it renders an arbitrary, capricious, whimsical,

or manifestly unreasonable judgment.” Burke v. Regalado, 935 F.3d 960, 1011 (10th

Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
999 F.3d 1240, Counsel Stack Legal Research, https://law.counselstack.com/opinion/derma-pen-v-4everyoung-limited-ca10-2021.